Abstract

CLC Number:

R994.11
R972

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2016/V13/I4/247

[1] 韦又嘉.注射用环磷腺苷葡胺致严重过敏反应1例[J].中国药物警戒, 2013,10(8):511.
[2] 石壬伟.环磷腺苷葡胺致1例速发性过敏性休克[J].药学与临床研究, 2011,13664(10):365.
[3] 宋爱丽,刘君.环磷腺苷葡氨致过敏性休克1例[J].药物流行病学杂志, 2012,21(10):487.
[4] 赵树芬,唐福爱.1例环磷腺苷葡胺致过敏性休克的护理[J].现代中西医结合杂志, 2008,17(3):385.
[5] 陈春枚、费燕.注射用环磷腺苷葡胺致过敏性休克[J].中国医院药学杂志, 2011,31(18):1566.
[6] 郑德泉,董闽田.环磷腺苷葡胺滴注致速发过敏性休克1例[J].临床军医杂志, 2011,39(5):91.
[7] 白杨.环磷腺苷葡氨致过敏性休克1例[J].中国实用乡村医学杂志, 2007,14(1):32.
[8] 黄岳林.环磷腺苷葡胺致过敏反应2例[J].医学信息, 2013,6(7):479.
[9] 田增英.静脉滴注环磷腺苷葡胺致严重神经、心脏不良反应1例[J]. 中国药物经济学, 2014,9(11):59-60.
[10] 孔飞飞,郭良君,谭兴起,等.静滴环磷腺苷葡胺注射液致寒战 1 例[J].药物流行病杂志, 2011,20(11):612.
[11] 王艳,沈佳炎.静脉滴注环磷腺苷葡胺注射液致不良反应3例[J].心脑血管病防治, 2015,15(3):256.
[12] 王井玲,徐锦龙,陈武,等。环磷腺苷葡胺致急性荨麻疹1例[J].中国药物应用与监测, 2015,12(3):195.
[13] 李洪杰. 环磷腺苷葡胺过敏1例[J].新医学,2005,36(11):646.
[14] 鲍隆梅,刘俊. 注射用环磷腺苷葡胺致过敏反应1例[J].山西医药杂志, 2015,44(4):487.
[15] 蔡媛媛.环磷腺苷葡胺致变态反应1例[J].护理实践与研究,2012,9(49):156.
[16] 王井玲,赵东瀛.注射用环磷腺苷葡胺致急性前壁心肌梗死1 例[J].医药导报, 2016,35(1):99.
[17] 王萍,沈洁,孔飞飞,等.静脉滴注环磷腺苷葡胺注射液致过敏反应1例[J].药学实践杂志, 2015,33(6):575.
[18] 张翼.右旋糖酐40致过敏性休克2例[J].医药导报, 2010,29(5):690.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.